Assessment of lipopolysaccharide-binding activity of Bifidobacterium and its relationship with cell surface hydrophobicity, autoaggregation, and inhibition of interleukin-8 production

Journal of Microbiology and Biotechnology

Volumn 17, Issue 7, 2007, Pages 1120-1126

  Park, Myeong Soo ^a,b   Kim, Min Jeong ^c   Ji, Geun Eog ^a,c  

^a Bifido Co   (South Korea)

^b Department of Hotel Culinary Art   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Aggregation; Bifidobacteria; Cell surface hydrophobicity; Interleukin 8; Lipopolysaccharides

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 8;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIFIDOBACTERIUM; BINDING AFFINITY; BINDING KINETICS; BIOTECHNOLOGY; CELL AGGREGATION; CELL STRAIN HT29; CELL SURFACE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; FECES; HUMAN; HUMAN CELL; HYDROPHOBICITY; INFLAMMATION; INHIBITION KINETICS; MICROBIAL ACTIVITY; NONHUMAN; SCREENING; STATISTICAL SIGNIFICANCE;

BIFIDOBACTERIUM; ESCHERICHIA COLI; FECES; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HT29 CELLS; HUMANS; HYDROPHOBICITY; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; PROBIOTICS; SEROTYPING; SURFACE PROPERTIES;

BIFIDOBACTERIUM; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 34547987813     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alander, M., R. Korpela, M. Saxelin, T. Vilpponen-Salmela, T. Matilla-Sandholm, and A. Wright. 1997. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett. Appl. Microbiol. 24: 361-364.
2. Bibiloni, R., R. N. Fedorak, G. W. Tannock, K. L. Madsen, P. Gionchetti, M. Campieri, C. De Simone, and R. B. Sartor. 2005. VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100: 1539-1546.
3. Boris, S., J. E. Suárez, and C. Barbés. 1997. Characterization of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate. J. Appl. Microbiol. 83: 413-420.
4. Cario, E. and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68: 7010-7017.
5. De Dooy, J. J., L. M. Mahieu, and H. P. Van Bever. 2001. The role of inflammation in the development of chronic lung disease in neonates. Eur. J. Ped. 160: 457-463.
6. De Man, J. C., M. Rogasa, and M. E. Sharpe. 1960. A medium for the cultivation of lactobacilli. J. Appl. Bacteriol. 23: 130-135.
7. Del Re, B., A. Busetto, G. Vignola, B. Sgorbati, and D. Palenzona. 1998. Autoaggregation and adhesion ability in a Bifidobacterium suis strain. Lett. Appl. Microbiol. 27: 307-310.
8. Del Re, B., B. Sgorbati, M. Miglioli, and D. Palenzona. 2000. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol. 32: 438-442.
9. Enrica, C., G. Simone, M. Diego, T. Isabella, and P. Carlo. 2005. Condition affecting cell surface properties of human intestinal bifidobacteria. Antonie Van Leeuwenhoek 88: 207-219.
10. Freter, M. 1992. Factors affecting the microecology of the gut, pp. 111-145. In R. Fuller (ed.), Probiotics. The Scientific Basis. Chapman and Hall, Glasgow.
11. Furrie, E., S. Macfarlane, A. Kennedy, J. H. Cummings, S. V. Walsh, D. A. O'Neil, and G. T. Macfarlane. 2005. Synbiotic therapy ( Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 54: 242-249.
12. Gionchetti, P, F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119: 305-309.
13. Guarner, F. and J. R. Malagelada. 2003. Gut flora in health and disease. Lancet 361: 512-519.
14. Kim, H. Y. and G. E. Ji. 2006. Effect of viability and integrity of Bifidobacterium on suppression of allergy in mice. J. Microbiol. Biotechnol. 16: 1010-1016.
15. Kim, I. H., M. S. Park, and G. E. Ji. 2003. Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocyte-like Caco-2 cells. J. Microbiol. Biotechnol. 13: 276-281.
16. Kim, N. J. and G. E. Ji. 2006. Modulatory activity of Bifidobacterium sp. BGN4 cell fractions on immune cells. J. Microbiol. Biotechnol. 16: 584-589.
17. Kok, R. G, A. De Waal, F. Schute, G. W. Welling, G. Weeken, and K. J. Hellingwere. 1996. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl. Environ. Microbiol. 62: 3668-3672.
18. Lim, N. K., J. C. Yoo, T. R. Park, and J. S. So. 1998. The relationship between cell surface hydrophobicity (CSH) and stress tolerance in Bifidobacterium spp. Food Sci. Biotechnol. 7: 66-70.
19. Madsen, K., A. Cornish, P. Soper, C. McKaigney, H. Jijon, C. Yachimec, J. Doyle, L. Jewell, and C. De Simone. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591.
20. McCarthy, J., L. O'Mahony, L. O'Callaghan, B. Sheil, E. E. Vaughan, N. Fitzsimons, J. Fitzgibbon, G. C. O'Sullivan, B. Kiely, J. K. Collins, and F. Shanahan. 2003. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52: 975-980.
21. Meijssen, M. A., S. L. Brandwein, H. C. Reinecker, A. K. Bhan, and D. K. Podolsky. 1998. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am. J. Physiol. 274: 472-479.
22. Ortega-Cava, C. F., S. Ishihara, M. A. Rumi, K. Kawashima, N. Ishimura, H. Kazumori, J. Udagawa, Y. Kadowaki, and Y. Kinoshita. 2003. Strategic compartmentalization of toll-like receptor 4 in the mouse gut. J. Immunol. 170: 3977-3985.
23. Pedersen, K. and G. W. Tannock. 1989. Colonization of the porcine gastrointestinal tract by lactobacilli. Appl. Environ. Microbiol. 55: 279-283.
24. Pérez, P. F., Y. Minnaard, E. A. Disalvo, and G. L. De Antoni. 1998. Surface properties of bifidobacterial strains of human origin. Appl. Environ. Microbiol. 64: 21-26.
25. Riedel, C. U., F. Foata, D. Philippe, O. Adolfsson, B. J. Eikmanns, and S. Blum. 2006. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation. World J. Gastroenterol. 12: 3728-3735.
26. Scardovi, V. 1986. Genus Bifidobacteria, pp. 1418-1434. In P. H. A. Sneah, N. S. Mair, M. E. Sharpe, and J. G. Holt (eds.), Bergey's Manual of Systematic Bacteriology, vol. 2, Williams and Wilkins, Baltimore.
27. Schiffrin, E. and G. Kociubinski. 2002. Endotoxin binding lactic acid bacteria and bifidobacteria. In Patent Publication Number WO 02/062360 A1.
28. Sellon, R. K., S. Tonkonogy, M. Dieleman, L. A. Schultz, W. Grenther, E. Balish, D. M. Rennick, and R. B. Sartor. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66: 5224-5231.
29. Vinderola, C. G., M. Medici, and G. Pedigon. 2004. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Microbiol. 96: 230-243.
30. Wadström, T. K., M. S. Anderson, L. Axelsson, S. Lindgren, and B. Gullman. 1987. Surface properties of lactobacilli isolate from the small intestine of pigs. J. Appl. Bacteriol. 62: 513-520.